Literature DB >> 10719169

Cloning of the bovine leukemia virus proteinase in Escherichia coli and comparison of its specificity to that of human T-cell leukemia virus proteinase.

G Zahuczky1, P Boross, P Bagossi, G Emri, T D Copeland, S Oroszlan, J M Louis, J Tözsér.   

Abstract

The proteinase of bovine leukemia virus (BLV) was cloned into pMal-c2 vector with N-terminal or with N- as well as C-terminal flanking sequences, and expressed in fusion with maltose binding protein. The proteinase self-processed itself from the fusion protein during expression and formed inclusion bodies. The enzyme was purified from inclusion bodies by cation-exchange chromatography followed by gel filtration. Specificity of the enzyme was compared to that of human T-cell leukemia proteinase type 1. Although the two viruses belong to the same subfamily of retroviruses, the differences in their proteinase specificity, based on kinetics with oligopeptide substrates representing naturally occurring cleavage sites as well as on inhibition pattern, appear to be pronounced.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10719169     DOI: 10.1016/s0167-4838(99)00240-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Amino acid preferences for a critical substrate binding subsite of retroviral proteases in type 1 cleavage sites.

Authors:  Péter Bagossi; Tamás Sperka; Anita Fehér; János Kádas; Gábor Zahuczky; Gabriella Miklóssy; Péter Boross; József Tözsér
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

2.  Amino acid preferences of retroviral proteases for amino-terminal positions in a type 1 cleavage site.

Authors:  Helga Eizert; Pálma Bander; Péter Bagossi; Tamás Sperka; Gabriella Miklóssy; Péter Boross; Irene T Weber; József Tözsér
Journal:  J Virol       Date:  2008-08-13       Impact factor: 5.103

3.  Comparative studies on retroviral proteases: substrate specificity.

Authors:  József Tözsér
Journal:  Viruses       Date:  2010-01-14       Impact factor: 5.818

4.  A look inside HIV resistance through retroviral protease interaction maps.

Authors:  Aleksejs Kontijevskis; Peteris Prusis; Ramona Petrovska; Sviatlana Yahorava; Felikss Mutulis; Ilze Mutule; Jan Komorowski; Jarl E S Wikberg
Journal:  PLoS Comput Biol       Date:  2007-01-24       Impact factor: 4.475

5.  Biochemical Characterization, Specificity and Inhibition Studies of HTLV-1, HTLV-2, and HTLV-3 Proteases.

Authors:  Norbert Kassay; János András Mótyán; Krisztina Matúz; Mária Golda; József Tőzsér
Journal:  Life (Basel)       Date:  2021-02-06

6.  Kinetics of Bovine leukemia virus aspartic protease reveals its dimerization and conformational change.

Authors:  Martín Fló; Federico Carrión; Natalia Olivero-Deibe; Sergio Bianchi; Madelón Portela; Florencia Rammauro; Beatriz Alvarez; Otto Pritsch
Journal:  PLoS One       Date:  2022-07-22       Impact factor: 3.752

7.  Different Mutation Tolerance of Lentiviral (HIV-1) and Deltaretroviral (BLV and HTLV) Protease Precursors.

Authors:  János András Mótyán; Norbert Kassay; Krisztina Matúz; József Tőzsér
Journal:  Viruses       Date:  2022-08-26       Impact factor: 5.818

Review 8.  Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human.

Authors:  Nicolas Gillet; Arnaud Florins; Mathieu Boxus; Catherine Burteau; Annamaria Nigro; Fabian Vandermeers; Hervé Balon; Amel-Baya Bouzar; Julien Defoiche; Arsène Burny; Michal Reichert; Richard Kettmann; Luc Willems
Journal:  Retrovirology       Date:  2007-03-16       Impact factor: 4.602

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.